Vuong Trieu - 22 Nov 2024 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Issuer symbol
OTLC
Transactions as of
22 Nov 2024
Transactions value $
$8,627
Form type
4
Filing time
26 Nov 2024, 11:33:58 UTC
Previous filing
27 Aug 2024
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $8,627 +298,499 +0.32% $0.0289 92,842,716 22 Nov 2024 Direct
holding OTLC Common Stock 16,780,384 22 Nov 2024 By Autotelic, Inc.
holding OTLC Common Stock 6,872,529 22 Nov 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On November 22, 2024, Dr. Trieu purchased 500,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0289.